MedPage Today (5/25, Monaco) reports, “Withdrawing from antidepressants likely won’t affect how well psilocybin works for treatment-resistant depression, according to a phase IIb randomized controlled trial.” The findings of an “analysis of 233 participants treated with a single dose of the investigational psilocybin treatment COMP360” were presented at the American Psychiatric Association annual meeting.
Related Links:
— MedPage Today (requires login and subscription)